HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Takehiko Koji Selected Research

chlorhexidine gluconate (Dyna-Hex)

3/2022Mitochonic acid-5 ameliorates chlorhexidine gluconate-induced peritoneal fibrosis in mice.
7/2021An inhibitor of Krüppel-like factor 5 suppresses peritoneal fibrosis in mice.
9/2016Chondroitin sulfate prevents peritoneal fibrosis in mice by suppressing NF-κB activation.
5/2015SAHA Suppresses Peritoneal Fibrosis in Mice.
1/2015The kampo medicine Daikenchuto inhibits peritoneal fibrosis in mice.
4/2013Involvement of leptin in the progression of experimentally induced peritoneal fibrosis in mice.
3/201322-Oxacalcitriol prevents progression of peritoneal fibrosis in a mouse model.
7/2012HSP47 siRNA conjugated with cationized gelatin microspheres suppresses peritoneal fibrosis in mice.
1/2012Involvement of lymphocyte infiltration in the progression of mouse peritoneal fibrosis model.
4/2011Thalidomide prevents the progression of peritoneal fibrosis in mice.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Takehiko Koji Research Topics

Disease

18Peritoneal Fibrosis
03/2022 - 01/2003
12Neoplasms (Cancer)
12/2021 - 08/2002
9Inflammation (Inflammations)
03/2022 - 12/2003
7Ischemia
05/2020 - 03/2003
6Infections
01/2019 - 04/2003
6Fibrosis (Cirrhosis)
01/2017 - 01/2008
6Glomerulonephritis
12/2012 - 12/2000
5Cholesteatoma
11/2014 - 01/2003
4Middle Ear Cholesteatoma
10/2015 - 01/2003
3Hepatocellular Carcinoma (Hepatoma)
12/2021 - 03/2007
3IGA Glomerulonephritis (IGA Nephropathy)
01/2005 - 07/2003
2Iron Overload
04/2020 - 11/2012
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2018 - 11/2013
2Nephrosclerosis
10/2016 - 01/2013
2Hypertension (High Blood Pressure)
10/2016 - 01/2013
2Lung Neoplasms (Lung Cancer)
06/2010 - 09/2004
2Reperfusion Injury
08/2008 - 12/2005
2Carcinogenesis
05/2006 - 01/2003
2Membranous Glomerulonephritis (Membranous Nephropathy)
01/2005 - 07/2003
2Lipoid Nephrosis (Glomerulonephritis, Minimal Change)
01/2005 - 07/2003
2Breast Neoplasms (Breast Cancer)
12/2004 - 11/2004
1Kidney Diseases (Kidney Disease)
03/2022
1Mitochondrial Diseases (Mitochondrial Disease)
03/2022
1Infertility (Sterility)
01/2021
1Acute Kidney Injury (Acute Renal Failure)
05/2020
1B-Cell Lymphoma (Lymphoma, B Cell)
02/2019
1Candidiasis (Moniliasis)
01/2019
1Intraabdominal Infections
01/2019
1Peritonitis
01/2019
1Contracture
01/2017
1Pulmonary Emphysema
06/2015

Drug/Important Bio-Agent (IBA)

13chlorhexidine gluconate (Dyna-Hex)FDA LinkGeneric
03/2022 - 01/2003
10Fibroblast Growth Factor 7FDA Link
10/2015 - 01/2003
9Fas Ligand Protein (Fas Ligand)IBA
08/2008 - 03/2002
8Proteins (Proteins, Gene)FDA Link
10/2015 - 12/2000
7Messenger RNA (mRNA)IBA
09/2012 - 12/2000
6CollagenIBA
01/2017 - 01/2003
5HSP47 Heat-Shock Proteins (Heat Shock Protein 47)IBA
01/2015 - 01/2003
4Histones (Histone)IBA
05/2018 - 11/2013
4DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA
09/2012 - 04/2002
4Caspase 3 (Caspase-3)IBA
11/2007 - 02/2005
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2007 - 10/2002
3AntibodiesIBA
02/2019 - 10/2002
3EnzymesIBA
04/2015 - 10/2002
3Snake Venoms (Snake Venom)IBA
12/2012 - 07/2008
3Estrogen ReceptorsIBA
05/2012 - 03/2003
3Estrogens (Estrogen)FDA Link
05/2012 - 03/2003
3Biological ProductsIBA
10/2008 - 08/2002
3Cytochromes c (Cytochrome c)IBA
11/2007 - 02/2005
3Estrogen Receptor alphaIBA
09/2006 - 03/2003
2Proliferating Cell Nuclear Antigen (PCNA)IBA
12/2021 - 04/2002
2CateninsIBA
12/2021 - 02/2019
2Connexin 43 (Connexin43)IBA
01/2021 - 07/2007
2Retinaldehyde (Retinal)IBA
05/2020 - 04/2004
2Lysine (L-Lysine)FDA Link
05/2018 - 11/2013
2keratinocyte growth factor receptorIBA
10/2015 - 11/2014
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
10/2015 - 11/2004
2Histone Deacetylase InhibitorsIBA
05/2015 - 04/2013
2ImmunosorbentsIBA
04/2015 - 10/2002
2Molecular Chaperones (Chaperone, Molecular)IBA
01/2015 - 09/2003
2Collagen Type III (Type III Collagen)IBA
03/2013 - 12/2008
2azelnidipineIBA
01/2013 - 12/2008
2olmesartanIBA
01/2013 - 12/2008
2NF-kappa B (NF-kB)IBA
11/2012 - 07/2003
2IronIBA
11/2012 - 03/2007
2Small Interfering RNA (siRNA)IBA
07/2012 - 01/2008
2Glucose (Dextrose)FDA LinkGeneric
01/2012 - 04/2004
2Angiotensin IIIBA
01/2012 - 01/2005
2ParaffinIBA
12/2009 - 11/2004
2TransferasesIBA
05/2009 - 05/2007
2Brain-Derived Neurotrophic Factor (BDNF)IBA
05/2007 - 04/2004
2Estrogen Receptor betaIBA
09/2006 - 03/2003
2ReninIBA
01/2005 - 02/2004
2Immunoglobulin A (IgA)IBA
01/2005 - 07/2003
2AngiotensinsIBA
01/2005 - 02/2004
2Erythromycin (Erycette)FDA LinkGeneric
06/2004 - 04/2003
2AntigensIBA
07/2003 - 04/2003
2Biotin (Vitamin H)FDA Link
08/2002 - 04/2002
14- (2,4- difluorophenyl)- 2- (1H- indol- 3- yl)- 4- oxobutanoic acidIBA
03/2022
1indoleacetic acid (indole acetic acid)IBA
03/2022
1tamibaroteneIBA
07/2021
1Factor V (Coagulation Factor V)IBA
07/2021
1ConnexinsIBA
01/2021
1Cisplatin (Platino)FDA LinkGeneric
05/2020
1Peptides (Polypeptides)IBA
05/2020
1prothymosin alphaIBA
05/2020
1EpitopesIBA
02/2019
1Micafungin (FK463)FDA Link
01/2019
1CytokinesIBA
01/2019
1Enhancer of Zeste Homolog 2 ProteinIBA
05/2018
1Collagen Type I (Type I Collagen)IBA
01/2017
1CurcuminIBA
10/2016
1Chondroitin Sulfates (Chondroitin Sulfate)IBA
09/2016
1Pancreatic Elastase (Elastase)IBA
06/2015

Therapy/Procedure

9Peritoneal Dialysis
03/2022 - 10/2004
6Therapeutics
01/2019 - 01/2003
5Intraperitoneal Injections
03/2022 - 01/2003
2Hepatectomy
04/2020 - 11/2012
2Transplantation
06/2010 - 08/2008
2Continuous Ambulatory Peritoneal Dialysis (CAPD)
09/2003 - 01/2003